Quantcast

Latest DCIS Stories

2011-05-24 08:00:00

REDWOOD CITY, Calif., May 24, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from a study of Oncotype DX® in patients with DCIS (ductal carcinoma in situ of the breast) conducted by the Eastern Cooperative Oncology Group (ECOG), a clinical trials cooperative group supported by the National Cancer Institute. The ECOG 5194 validation study met its primary endpoint by demonstrating that a pre-specified Oncotype DX DCIS...

2011-03-14 10:53:00

Combining Radiation and Tamoxifen Therapy to Lumpectomy for DCIS Reduces Risk of Cancer Recurrence PITTSBURGH, March 14, 2011 /PRNewswire-USNewswire/ -- Adding radiation and/or tamoxifen therapy to the treatment plan of women who undergo a lumpectomy for ductal carcinoma in situ (DCIS), the most common form of non-invasive breast cancer, reduces the risk of a dangerous cancer recurrence, according to a study published today in the Journal of the National Cancer Institute by physicians at...

2011-03-11 17:08:43

Women with ductal carcinoma in situ"”DCIS"”who later develop invasive breast cancer in the same breast are at higher risk of dying from breast cancer than those who do not develop invasive disease, according to a study published online March 11 in the Journal of the National Cancer Institute. Retrospective studies of women with DCIS have compared breast conserving surgery (lumpectomy) to mastectomy and found that survival rates are similar. However, women who have lumpectomy...

2011-01-06 09:38:32

(Ivanhoe Newswire) -- Non-invasive breast cancer, or ductal carcinoma in situ (DCIS), is commonly treated with either breast-conserving surgery (with or without follow-up radiation) or mastectomy. Choosing a treatment depends on clinical factors, the treating surgeon, and patient preferences. Long-term health outcomes depend on which treatment is received. According to a new study, health outcomes are also associated with the treating surgeon. To figure out the effectiveness of each treatment...

2011-01-04 04:00:59

Ductal carcinoma in situ (DCIS), or non-invasive breast cancer, is typically treated with either breast-conserving surgery"”with or without follow-up radiation"”or mastectomy. The treatment choice depends on clinical factors, the treating surgeon, and patient preferences. Long-term health outcomes (disease-free survival) depend on the treatments received. According to a study published January 3 in The Journal of the National Cancer Institute , however, health outcomes also are...

2010-11-30 15:17:44

In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer. The researchers saw such a striking decrease, they believe they also have uncovered indirect evidence that hormones promote breast tumor growth. The declines occurred in the age groups that most widely embraced...

2010-07-29 07:05:00

NORTHFIELD, Ill., July 29 /PRNewswire-USNewswire/ -- Recent media reports of potential misdiagnosis of early-stage breast cancer may frighten women away from breast cancer screening that could save their lives. Rather than shying away from screening, women should know the questions to ask and be confident about weighing their options, according to Susan G. Komen for the Cure®, the world's largest breast cancer organization, and the College of American Pathologists (CAP),...

2010-04-29 09:17:49

For the first time, scientists have discovered a way to predict whether women with ductal carcinoma in situ (DCIS) "“ the most common form of non-invasive breast cancer "“ are at risk of developing more invasive tumors in later years. As a result of the finding, women with DCIS will have the opportunity to be more selective about their treatment, according to the scientists. "Women will have much more information, so they can better know their risk of developing invasive cancer,''...

2010-02-08 10:18:13

A new analysis has found that women with medium or low levels of income are particularly susceptible to anxiety and depression after being diagnosed with the precancerous breast condition, ductal carcinoma in situ (DCIS). Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study suggests that women with financial hardship may benefit from psychosocial interventions that are designed to accommodate their unique needs. While research suggests that...

2010-01-14 14:19:50

An article and commentary published online January 13 in the Journal of the National Cancer Institute review available data on diagnosis and management of ductal carcinoma in situ (DCIS), and offer recommendations for the field. These include identification of better risk stratification methods, consideration of the elimination of the word "carcinoma" from the name, and further investigation into whether imaging technology and guidelines can be modified to focus on high-risk lesions. The...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related